BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal

fiercebiotech.com/biotech/biontech-buys-german-mrna-vaccine-peer-curevac-12b-all-stock-deal

This story appeared on fiercebiotech.com, 2025-06-12 21:37:55.322000.
The Entire Business World on a Single Page. Free to Use →